1
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The Value of Serum Laminin P1 in Monitoring Disease Activity in Patients with Systemic Lupus Erythematosus

, , , &
Pages 417-422 | Received 06 Apr 1988, Published online: 12 Jul 2009

References

  • Belmont H M, Hopkins P, Edelson H S, Kaplan H B, Ludewig R, Weissmann G, Abrahamson S. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum 1986; 29: 1085–9
  • Wangel A. Serological test in the assessment of disease activity in systemic lupus erythematosus. Scand J Rheumatol 1986; 15: 353–5
  • Swaak A JG, Rooyen A V, Vogelaar C, Pillay M, Hack E. Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. Rheumatol Int 1986; 6: 221–6
  • Krauledat P B, Krapf F E, Manger B, Kalden J R. Evaluation of plasma C3d and immune complex determination in assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica. Rheumatol Int 1985; 5: 97–101
  • Valentijn R M, Van Overhagen H, Hazevoet H M, Hermans J, Cats A, Daha M R, Van Es L A. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 904–13
  • Gabrielli A, Sbarbati A, Marchegiani G, Rupoli S, Montroni M, Cinti S, Danielli G. Evidence of immune deposits and of basement membrane alterations in dermal vessels of normal skin of patients with essential mixed cryoglobulinemia. Arthritis Rheum 1987; 30: 884–93
  • Norton W L, Hurd E R, Lewis D C, Ziff M. Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med 1968; 71: 919–33
  • Klemperer P, Pollack A D, Baehr G. Diffuse collagen disease. Acute disseminated lupus erythe-matodes and diffuse scleroderma. JAMA 1942; 119: 331–2
  • Timpl R, Rohde H, Gehron-Robey P, Rennard S, Foidart J M, Martin G R. Laminin–a glycoprotein from basement membranes. J Biol Chem 1979; 254: 9933–7
  • Timpl R, Rohde H, Risteli L, Ott U, Gehron-Robey P, Martin G R. Laminin. Methods Enzymol 1982; 82: 831–8
  • Risteli L, Timpl R. Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem J 1981; 193: 749–55
  • Brocks D G, Strecker H, Neubauer H P, Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem 1986; 32: 787–91
  • Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, Schaller J G, Talal N, Winchester R J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
  • Hull C M, Nie N M. Statistical package for the social sciences (Update). McGraw-Hill, New York 1979
  • Biegelmayer C, Feiks A, Rudelstorfer R. Laminin in pregnancy. Gynecol Obstet Invest 1986; 22: 7–11
  • Högemann B, Voss B, Altenwerth F J, Schneider M, Rauterberg J, Gerlach U. Concentrations of 7S collagen and laminin PI in sera of patients with diabetes mellitus. Klin Wochenschr 1986; 64: 382–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.